[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![wallstengine Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1508426880860704771.png) Wall St Engine [@wallstengine](/creator/twitter/wallstengine) on x 71.9K followers
Created: 2025-07-16 20:03:25 UTC

Sarepta $SRPT is cutting XX% of its workforce—about XXX employees—as part of a restructuring plan aimed at reducing annual costs by ~$400M starting in 2026. The company will focus on siRNA programs while pausing some gene therapy efforts, including most limb-girdle muscular dystrophy candidates.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945575017259176267/c:line.svg)

**Related Topics**
[$400m](/topic/$400m)
[chapter 11](/topic/chapter-11)
[$srpt](/topic/$srpt)
[sarepta therapeutics inc](/topic/sarepta-therapeutics-inc)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/wallstengine/status/1945575017259176267)